Not sure if this was highlighted here, but this is great news.
Buried in recent earnings report.
"Gastrointestinal cancers account for 145,000 or 25% of all U.S. cancer deaths annually and represent a significant market opportunity for future products. In February 2015, we amended and restated our license agreement with MAYO to extend our working relationship for an additional five years and to extend our collaboration efforts to focus on gastrointestinal cancers. In January 2016, we further amended our license agreement to broaden our collaboration efforts"
Multiple times and dates by my son and I in Milwaukee, WI. I saw during 60 minutes program and again the next day during local news. I had a check up with my doctor yesterday and he is now having patients specifically ask for Cologuard without him mentioning it.
15% were flat
From the study:
"In the trials, 2,931 polyps were removed from 1,340 patients. Of 1,911 ademonas removed from patients, accounting for 65.2 percent of polyps doctors removed, 15.3 percent were flat, while 84.7 percent were polypoid."